Corvus Pharmaceuticals (CRVS) Total Non-Current Liabilities (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Total Non-Current Liabilities of $59,000 for Q2 2026, down 85.7% from $414,000 a year earlier and down 58.7% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals posted Total Non-Current Liabilities of $229,000, down 61.4% from FY2024.
- Total Non-Current Liabilities has declined for three consecutive years, though with a four-year compound annual growth rate of 21.5% (FY2021 to FY2025).
- By year, Total Non-Current Liabilities came in at $593,000 in FY2024 (-8.5%), $648,000 in FY2023 (-34.2%), $985,000 in FY2022 (+838.1%) and $105,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2015.
- Year over year, Total Non-Current Liabilities has now declined in each of the last 13 quarters, with an average decline of 40.3% over the last eight quarters.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q4 2022 (growth of 838.1%); the low point was Q2 2026 (a decline of 85.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $143,000 (Q1 2026), $229,000 (Q4 2025) and $321,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Corvus Pharmaceuticals | 989.26 Mn | 477.70 Mn | - | 59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | 321,000.00 |
| Jun 30, 2025 | 414,000.00 |
| Mar 31, 2025 | 503,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Sep 30, 2024 | 625,000.00 |
| Jun 30, 2024 | 531,000.00 |
| Mar 31, 2024 | 595,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 773,000.00 |
| Mar 31, 2023 | 903,000.00 |
| Dec 31, 2022 | 985,000.00 |
| Sep 30, 2022 | 945,000.00 |
| Jun 30, 2022 | 1.02 Mn |
| Dec 31, 2021 | 105,000.00 |
| Dec 31, 2018 | 7.03 Mn |
| Sep 30, 2018 | 7.75 Mn |
API Access
Corvus Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();